FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Champignon Appoints Former President of Red Bull Canada to Special Advisory Committee.”
Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, has further bolstered its pharmaceutical, nutraceutical and CPG marketing/distribution competencies via the appointment of the former President of Red Bull Canada, Mr. Jim Bailey, to its Special Advisory Committee. Mr. Bailey previously served as the Global Chief Marketing Officer for Merrell Outdoors, overseeing both product and consumer marketing with annual revenues of US$600M. Prior to his tenure at Merrel, Jim served as President of Red Bull Canada, playing an instrumental role in launching the Red Bull brand in Canada and growing the business to $150M in annual revenue with over 300 employees nationwide.
Champignon Brands Inc. is a research-driven company specializing in the formulation of a suite of medicinal mushrooms health products as well as novel ketamine, anaesthetics and adaptogenic delivery platforms for the nutritional, wellness and alternative medicine industries. Via its vertically integrated alternative medicine product range, Champignon is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (PTSD), as well as substance and alcohol use disorders. Under a collaborative research agreement with the University of Miami’s Miller School of Medicine, the Company is conducting preclinical studies and eventual human clinical trials, with the objective of demonstrating safety and efficacy of the combination of psilocybin and cannabidiol in treating mTBI with PTSD or stand-alone PTSD.
The fast pace of technological change in the biotechnology industry and the shifting market demands require continuous innovation. This, in turn, puts pressure on companies to invest in Research and Development. As such, organizations such as the DBT (Department of Biotechnology), together with government-funded institutions and other autonomous organizations, represent the biotechnology sector and promote funding to support R&D and various new product development endeavors. The rise in demand for these therapeutics and diagnostic solutions on principles of red biotechnology, DNA sequencing, and recombinant technology is anticipated to help the industry grow even further. And, the increasing occurrence of diseases such as hepatitis B, cancer, as well as viral infections such as the current pandemic, push biopharmaceutical innovators to lead the charge in the fight against these ailments. In fact, several biotechs over the last month have made announcements that vaccines or possible treatments for the pandemic are being developed. Furthermore, the global biotechnology market size is expected to reach USD 727.1 Billion by 2025 while at a CAGR of 7.4%, according to a new report by Grand View Research, Inc.
There are several incredible and innovative achievements scientists and researchers have made in biotechnology in recent years. Among the fields of study are gene editing, tissue engineering and regeneration, nanobiotechnology and others. In addition, new segments under the biotech umbrella are constantly being created. For example, the medical cannabis segments that emerged in recent years, or the growing acceptance of psychedelic drugs being used as a treatment for various health conditions including depression, panic disorders, post-traumatic stress disorder (PTSD), and opiate addiction. Overall, in recent years, several psychedelic drug product launches and developments were announced and initiated by companies worldwide, including established pharmaceuticals like Johnson & Johnson.
For more information, please visit: Champignon Brands Inc.
For more corporate news on Champignon Brands Inc., check out the Buzz on the Street
About Buzz on the Street: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.